Crowley Wealth Management Inc. Acquires New Holdings in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Crowley Wealth Management Inc. acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) during the fourth quarter, HoldingsChannel reports. The fund acquired 1,000 shares of the exchange traded fund’s stock, valued at approximately $51,000.

Separately, Jane Street Group LLC lifted its position in ProShares Ultra Nasdaq Biotechnology by 8.4% during the third quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock valued at $306,000 after purchasing an additional 374 shares during the period.

ProShares Ultra Nasdaq Biotechnology Trading Up 0.6 %

Shares of BIB stock opened at $52.90 on Monday. ProShares Ultra Nasdaq Biotechnology has a 12 month low of $47.20 and a 12 month high of $69.56. The stock has a market cap of $62.42 million, a P/E ratio of 26.77 and a beta of 1.63. The company has a 50 day simple moving average of $54.11 and a two-hundred day simple moving average of $57.69.

ProShares Ultra Nasdaq Biotechnology Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.